SHVM

19th Annual Scientific Sessions:

Metabolic Modulation of Diabetes and Cardiovascular Diseases: From Mechanisms to Novel Treatment

SHVM

19th Annual Scientific Sessions:

Metabolic Modulation of Diabetes and Cardiovascular Diseases: From Mechanisms to Novel Treatment

Seoul, South Korea 16-19 October 2022

Seoul, South Korea
16-19 October 2022

Please check the Information page for details regarding the COVID situation when planning your trip.

IMPORTANT DATES

Opening of registrations and abstract submissions:
27 April 2022

Abstract submission deadline:
5 July 2022

Early bird payments:
12 August 2022

Registrations and late payment:
12 September 2022

Notification of abstract selections:
29 July 2022

Welcome

We are pleased to invite you to the 19th Annual Meeting of the Society for Heart and Vascular Metabolism (SHVM), to be held in Seoul, the dynamic metropolis and capital of Korea, from October 16 to 19, 2022. The Society was founded in 2000, with the intent of providing a forum for the free exchange of ideas by a group of investigators with a special interest in the multiple roles of intermediary metabolism in the cardiovascular system. An important aim of the Society is to foster interactions between young investigators and senior scientists in an informal setting. Our meetings are deliberately designed to maximize these interactions.

The scientific focus of the 2022 meeting is "Metabolic Modulation of Diabetes and Cardiovascular Diseases: From Mechanisms to Novel Treatment". Evidence indicates that metabolic alterations are central drivers of cardiovascular disease. Greater than 50% of patients with heart failure, manifest as heart failure with preserved ejection fraction, commonly in association with obesity, metabolic syndrome, and diabetes mellitus. Novel therapeutic strategies, directed at intermediary metabolism are being developed that show high promise in the treatment of diabetes and its cardiovascular complications including heart failure.

This meeting will focus on metabolic modulation of diabetes and cardiovascular diseases. Invited speakers will highlight our current understanding of metabolic signaling pathways in blood vessels and heart, that can be targeted for the treatment of metabolic cardiovascular diseases.

We hope that you will join us for this annual SHVM meeting and that numerous new collaborations will be created.

If you’d like to witness the magic of colorful turning leaves, and cozy weather, October is the best season to visit Korea.

See you in Seoul!

The Organising Committee

Jaetaek Kim

Jaetaek Kim
Seoul, South Korea
(Co-Chair)

InKyu Lee

In Kyu Lee
Daegu, South Korea
(Co-Chair)

Dale Abel

E. Dale Abel
Los Angeles, CA, USA
(Co-Chair)

Terje Larsen

Terje Larsen
Tromsø, Norway
(SHVM President)

Florin Despa

Florin Despa
Lexington, KY, USA
(SHVM Secretary/Treasurer)

Jin Han

Jin Han
Busan, South Korea

Yong Seek Park

Yong Seek Park
Seoul, South Korea

Junghyun Noh

Junghyun Noh
Goyang, South Korea

Wang Soo Lee

Wang Soo Lee
Seoul, South Korea

Hyoung Kyu Kim

Hyoung Kyu Kim
Busan, South Korea